Skip to main content
Caplight Logo









Regulonix

Regulonix

Private
Tucson, ArizonaHealthcare & Life Scienceshttps://regulonix.com

Last Round

Seed

Jul 10, 2018

Total Funding Raised

$2M

Company Overview

Regulonix is a biotechnology company developing non-opioid therapeutics to relieve chronic pain by indirectly targeting the NaV1.7 sodium channel.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

non-opioid therapeuticschronic pain treatmentsmall molecule inhibitorsNaV1.7 targetopioid alternativenon-addictive pain reliefCRMP2 inhibitorindirect channel modulationneuropathic painundruggable targetspreclinical biotechpharma licensingdrug discoverySmall Business Technology TransferSTTR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Regulonix Comparables

Compare Regulonix with similar companies based on industry and business-model similarity.

Regulonix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Navega Therapeutics
79%
Eli Lilly and Company
78%
Latigo Biotherapeutics
78%

Regulonix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 10, 2018

Regulonix Investors

Notable investors and investment history

Regulonix investors
InvestorRounds
Desert AngelsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 10, 2018

    $2M round led by Uventurecap.

Regulonix Filings

Explore SEC and related filing metadata, where available.

Regulonix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Regulonix's valuation, stock price, and market status.

Is Regulonix a public or private company?

Regulonix is a private company.

What is the current stock price of Regulonix?

Regulonix is a private company with no public stock price. No recent secondary market data is available.

How much is Regulonix worth (valuation)?

Valuation information for Regulonix is not publicly available.

Can I buy Regulonix stock?

Regulonix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Regulonix's last funding round?

Regulonix's most recent funding round was Seed on July 10, 2018.

Who are the main investors in Regulonix?

Key investors in Regulonix include Desert Angels.

Will Regulonix IPO soon?

No public IPO plans have been announced for Regulonix.

How can I track Regulonix secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Regulonix's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTucson, Arizona
Year Founded2017
Last FundingJul 10, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?